Ali Kamen

Ali Kamen

Auto-generated profile, based on publicly available information

Ali Kamen

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
DWDavid Winkel
David Winkel
CWChristian Wetterauer
Christian Wetterauer
MMMarc Oliver Matthias
Marc Oliver Matthias
BLBin Lou
Bin Lou
BSBIBO SHI
BIBO SHI
DBDaniel T. Boll
Daniel T. Boll
Background: Opportunistic prostate cancer (PCa) screening is a controversial topic. Magnetic resonance imaging (MRI) has proven to detect prostate cancer with a high sensitivity and specificity, leading to the idea to perform an image-guided prostate cancer (PCa) screening; Methods: We evaluated a prospectively enrolled cohort of 49 healthy men participating in a dedicated image-guided PCa screening trial employing a biparametric MRI (bpMRI) protocol consisting of T2-weighted (T2w) and diffusion weighted imaging (DWI) sequences. Datasets were analyzed both by human readers and by a fully automated artificial intelligence (AI) software using deep learning (DL). Agreement between the algorithm and the reports—serving as the ground truth—was compared on a per-case and per-lesion level using metrics of diagnostic accuracy and k statistics; Results: The DL method yielded an 87% sensitivity (33/38) and 50% specificity (5/10) with a k of 0.42. 12/28 (43%) Prostate Imaging Reporting and Data System (PI-RADS) 3, 16/22 (73%) PI-RADS 4, and 5/5 (100%) PI-RADS 5 lesions were detected compared to the ground truth. Targeted biopsy revealed PCa in six participants, all correctly diagnosed by both the human readers and AI. Conclusions: The results of our study show that in our AI-assisted, image-guided prostate cancer screening the software solution was able to identify highly suspicious lesions and has the potential to effectively guide the targeted-biopsy workflow.

1 September 2021 in European Journal of Radiology
Verified
Journal Article
Closed access
SYSeo Yeon Youn
Seo Yeon Youn
MCMoon-hyung Choi
Moon-hyung Choi
DKDong Hwan Kim
Dong Hwan Kim
YLYoung Joon Lee
Young Joon Lee
HHHenkjan J. Huisman
Henkjan J. Huisman
AKAli Kamen
Ali Kamen

1 March 2025 in Radiology
Verified
Journal Article
Closed access
YLYoung Joon Lee
Young Joon Lee
HMHyong Woo Moon
Hyong Woo Moon
MCMoon-hyung Choi
Moon-hyung Choi
SJSeung Eun Jung
Seung Eun Jung
YPYong Hyun Park
Yong Hyun Park
AKAli Kamen
Ali Kamen
A commercial MRI-based deep learning algorithm for prostate cancer detection showed greater positive predictive value, despite its lower sensitivity, potentially allowing it to assist radiologists in biopsy planning.

29 September 2020
Verified
Book Chapter
Closed access
PDF file
XYXin Yu
Xin Yu
BLBin Lou
Bin Lou
DZDonghao Zhang
Donghao Zhang
DWDavid Winkel
David Winkel
NANacim Arrahmane
Nacim Arrahmane
AKAli Kamen
Ali Kamen

27 November 2021 in iScience
Verified
Journal Article
Open access
VSVivek Singh
Vivek Singh
RKRishikesan Kamaleswaran
Rishikesan Kamaleswaran
DCDonald Chalfin
Donald Chalfin
ABAntonio Buño-Soto
Antonio Buño-Soto
JRJanika San Roman
Janika San Roman
AKAli Kamen
Ali Kamen
The SARS-CoV-2 virus has caused tremendous healthcare burden worldwide. Our focus was to develop a practical and easy-to-deploy system to predict the severe manifestation of disease in patients with COVID-19 with an aim to assist clinicians in triage and treatment decisions. Our proposed predictive algorithm is a trained artificial intelligence-based network using 8,427 COVID-19 patient records from four healthcare systems. The model provides a severity risk score along with likelihoods of various clinical outcomes, namely ventilator use and mortality. The trained model using patient age and nine laboratory markers has the prediction accuracy with an area under the curve (AUC) of 0.78, 95% CI: 0.77–0.82, and the negative predictive value NPV of 0.86, 95% CI: 0.84–0.88 for the need to use a ventilator and has an accuracy with AUC of 0.85, 95% CI: 0.84–0.86, and the NPV of 0.94, 95% CI: 0.92–0.96 for predicting in-hospital 30-day mortality.

1 September 2024 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
HLHao Li
Hao Li
HLHan Liu
Han Liu
HBHeinrich Johannes Eckhard von Busch
Heinrich Johannes Eckhard von Busch
RGRobert Grimm
Robert Grimm
HHHenkjan J. Huisman
Henkjan J. Huisman
BLBin Lou
Bin Lou
To determine whether the unsupervised domain adaptation (UDA) method with generated images improves the performance of a supervised learning (SL) model for prostate cancer (PCa) detection using multisite biparametric (bp) MRI datasets. This retrospective study included data from 5150 patients (14 191 samples) collected across nine different imaging centers. A novel UDA method using a unified generative model was developed for PCa detection using multisite bpMRI datasets. This method translates diffusion-weighted imaging (DWI) acquisitions, including apparent diffusion coefficient (ADC) and individual diffusion-weighted (DW) images acquired using various b values, to align with the style of images acquired using b values recommended by Prostate Imaging Reporting and Data System (PI-RADS) guidelines. The generated ADC and DW images replace the original images for PCa detection. An independent set of 1692 test cases (2393 samples) was used for evaluation. The area under the receiver operating characteristic curve (AUC) was used as the primary metric, and statistical analysis was performed via bootstrapping. For all test cases, the AUC values for baseline SL and UDA methods were 0.73 and 0.79 (P < .001), respectively, for PCa lesions with PI-RADS score of 3 or greater and 0.77 and 0.80 (P < .001) for lesions with PI-RADS scores of 4 or greater. In the 361 test cases under the most unfavorable image acquisition setting, the AUC values for baseline SL and UDA were 0.49 and 0.76 (P < .001) for lesions with PI-RADS scores of 3 or greater and 0.50 and 0.77 (P < .001) for lesions with PI-RADS scores of 4 or greater. UDA with generated images improved the performance of SL methods in PCa lesion detection across multisite datasets with various b values, especially for images acquired with significant deviations from the PI-RADS-recommended DWI protocol (eg, with an extremely high b value). Keywords: Prostate Cancer Detection, Multisite, Unsupervised Domain Adaptation, Diffusion-weighted Imaging, b Value Supplemental material is available for this article. © RSNA, 2024